New cancer risk gene found

Carrying a mutated BRIP1 gene doubles the risk of breast cancer — by aged 70 these women's risk rises from 1-in-12 to 1-in-6.

Nazneen Rahman, Professor of Cancer Genetics
Nazneen Rahman, Professor of Cancer Genetics

The Institute of Cancer Research study (pub: Nature Genetics) focused on the BRIP1 gene in 1,212 women with breast cancer who had a family history of the disease that was not due to the known breast cancer genes, BRCA1 or BRCA2, comparing these with 2,081 healthy people. Nine BRIP1 mutations were found in the cancer group, only two in the healthy. The researchers concluded that carrying a faulty version of BRIP1 doubled women’s risk of developing the disease – taking their risk by aged 70 from 1-in-12 to around 1-in-6.

Lead author Nazneen Rahman, Professor of Cancer Genetics at the institute, said there are many more genes to be found ‘…but with each step we are making progress.’

16.11.2006

Related articles

Photo

News • Molecular imaging

HER2-positive breast cancer: PET/CT technique shows promise for predicting treatment response

Molecular imaging with ⁶⁸Ga-HER2 PET/CT may provide an early, targeted measure of how well treatment is working in patients with HER2-positive breast cancer, according to new research.

Photo

News • Trial investigates combined benefits

Liquid biopsy and mammography: a perfect match for breast cancer detection?

Could a liquid biopsy blood test help detect breast cancer earlier than a mammogram alone? A new clinical trial to evaluate this question has just started.

Photo

News • RxFINE-Low trial

Evaluating chemotherapy benefit in high-risk early-stage breast cancer

Can patients with high anatomic risk but low genomic risk for early-stage ER+/HER2- breast cancer do similarly well without chemotherapy? A new trial aims to evaluate the benefits for this subgroup.

Subscribe to Newsletter